Open AccessExcess Cancer Cases and Medical Costs Due to Suboptimal Human Papillomavirus Vaccination Coverage in California
Author(s) -
Eleonore B. Baughan,
Erin Keizur,
Christopher A. Damico,
Elizabeth Mayfield Arnold,
Jamie Ko,
Jeffrey D. Klausner
Publication year - 2019
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001016
Subject(s) - medicine , vaccination , cohort , cervical cancer , cancer , human papillomavirus , cohort study , demography , environmental health , immunology , sociology
Human papillomavirus (HPV) vaccination coverage continues to be at low to moderate levels throughout the United States. HPV infection is linked to multiple types of cancers resulting in high economic and health burden. We aimed to estimate the excess number of cancer cases and associated medical costs due to current HPV vaccination coverage for a 20-year-old birth cohort in California.